Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRN Amarin Corporation plc daily Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.79 Insider Own0.20% Shs Outstand182.51M Perf Week22.11%
Market Cap423.42M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float149.51M Perf Month5.45%
Income-140.60M PEG- EPS next Q-0.12 Inst Own38.80% Short Float15.38% Perf Quarter-3.33%
Sales64.30M P/S6.59 EPS this Y68.90% Inst Trans9.38% Short Ratio13.18 Perf Half Y38.92%
Book/sh-0.63 P/B- EPS next Y54.90% ROA-73.30% Target Price8.00 Perf Year24.06%
Cash/sh0.75 P/C3.11 EPS next 5Y- ROE156.90% 52W Range0.78 - 3.33 Perf YTD136.81%
Dividend- P/FCF- EPS past 5Y15.00% ROI-37.80% 52W High-32.43% Beta1.17
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin63.90% 52W Low188.46% ATR0.18
Employees201 Current Ratio3.40 Sales Q/Q40.50% Oper. Margin- RSI (14)53.52 Volatility10.22% 9.25%
OptionableYes Debt/Eq- EPS Q/Q-600.00% Profit Margin- Rel Volume1.16 Prev Close2.32
ShortableYes LT Debt/Eq- EarningsAug 06 AMC Payout- Avg Volume1.74M Price2.25
Recom2.00 SMA203.33% SMA50-1.16% SMA20021.27% Volume1,675,353 Change-3.02%
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Jul-20-10Initiated Wedbush Outperform $5
Feb-03-09Initiated Rodman & Renshaw Mkt Outperform $3.50
Nov-06-08Initiated Rodman & Renshaw Mkt Outperform $3.50
Sep-02-15 07:00AM  Amarin to Present at the Rodman & Renshaw 2015 Global Investment Conference Marketwired +9.43%
Aug-28-15 05:15PM  3 Battleground Biotech Stocks I Would Avoid at All Costs at Motley Fool +6.70%
Aug-27-15 07:00AM  Amarin Announces Encore Presentation of Results of the Apolipoprotein C-III Post-Hoc Analysis From MARINE and ANCHOR Studies of Vascepa(R) at the European Society of Cardiology (ESC) 2015 Annual Congress Marketwired +10.00%
Aug-25-15 02:34PM  Nine Explanations For Why The FDA Is Approving Almost Every New Drug Application at Forbes
Aug-17-15 02:00PM  MTNB: Update on Second Quarter Financials
Aug-15-15 01:04PM  AMARIN CORP PLC\UK Financials
Aug-11-15 07:00AM  Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives Marketwired
Aug-10-15 03:21PM  Amarin (AMRN) Stock Loss Estimates Raised at Oppenheimer at TheStreet
08:17AM  Thalidomide, Drug Marketing And FDA Oversight at Forbes
Aug-07-15 10:08PM  Amarin Wins Off-Label Ruling Against FDA at The Wall Street Journal +14.22%
04:42PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
04:22PM  Court sides against FDA in "off-label" drug promotion case
03:29PM  Why Amarin Corporation plc (ADR) is Moving Higher Today at Motley Fool
01:38PM  Judges Ruling Lets Drugmaker Promote Use Without FDA Approval at Bloomberg
12:57PM  [$$] Amarin Wins Off-Label Case Against FDA at The Wall Street Journal
10:49AM  First Amendment Decision a Win for Amarin and Physician Plaintiffs Marketwired
12:34AM  Edited Transcript of AMRN earnings conference call or presentation 6-Aug-15 8:30pm GMT
Aug-06-15 04:03PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations Marketwired
07:07AM  Q2 2015 Amarin Corporation PLC Earnings Release - Time Not Supplied
Aug-05-15 04:27PM  Poseida Therapeutics, Inc., Expands Board of Directors GlobeNewswire -5.00%
04:15PM  Amarin to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, August 6, 2015 Accesswire
Jul-31-15 07:00AM  Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the Kern Lipid Conference Marketwired
Jul-30-15 07:00AM  Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015 Marketwired
Jul-11-15 10:03AM  3 Things You Should Know About Amarin Plc at Motley Fool
Jul-10-15 04:16PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
09:35AM  5 Stocks Ready for Breakouts -- Must-See Charts at TheStreet
Jun-11-15 07:00AM  New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago Marketwired
Jun-08-15 07:00AM  New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston Marketwired
Jun-03-15 03:40PM  Matinas and Amarin's Destinies are Linked as MAT9001 Outshines Vascepa Accesswire +5.65%
May-29-15 04:43PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
08:37AM  Amarin (AMRN) in Focus: Stock Surges 19% in Session - Tale of the Tape
07:20AM  What Biotechnology Stocks Will Be Next To Enjoy The Bull Market? Accesswire
May-28-15 03:46PM  Amarin's Lawsuit Could Have Huge Benefits For Pharma Industry And Dire Consequences For Consumers at Forbes +18.97%
02:29PM  Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules Marketwired
02:26PM  U.S. court grants exclusivity for Amarin's Vascepa
May-26-15 05:00PM  Amarin to Present at the Jefferies 2015 Global Healthcare Conference Marketwired
May-18-15 08:31AM  Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape
May-08-15 08:16AM  Secret Letter To Doctors Shows That The Amarin Lawsuit Is About Marketing, Not Free Speech at Forbes -6.57%
07:07AM  Q1 2015 Amarin Corporation PLC Earnings Release - Before Market Open
06:19AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
06:00AM  Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations Marketwired
May-07-15 09:11PM  Drug Firms Challenge FDA Over Free Speech at The Wall Street Journal
05:52PM  Irish drugmaker sues FDA under First Amendment Reuters
04:59PM  Amarin sues U.S. FDA on free speech grounds over off-label speech Reuters
04:50PM  Prescription Fish Oil Maker Hires Top Lawyer To Sue FDA On First Amendment Grounds at Forbes
04:10PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
04:05PM  Amarin to Host First Quarter 2015 Earnings Conference Call and Webcast Live on Friday, May 8, 2015 Accesswire
May-05-15 06:34PM  Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015 at noodls
05:00PM  Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015 Marketwired
Apr-28-15 11:09AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation AMRN Accesswire
06:32AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
Apr-09-15 08:55AM  How Amarin Corporation (AMRN) Stock Stands Out in a Strong Industry - Tale of the Tape
Apr-08-15 08:26AM  Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts at noodls
08:00AM  Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts Marketwired
Mar-30-15 04:32PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
Mar-16-15 05:44PM  Amarin, LeapFrog Lead Monday's After-Hours Movers
05:10PM  New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents at noodls
04:30PM  New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents Marketwired
Mar-14-15 09:20AM  8 Analyst Stocks Under $10 With Massive Upside Calls at 24/7 Wall St.
Mar-13-15 03:06PM  3 Biotech Stocks on Traders' Radars: Technical Charts at TheStreet +21.85%
09:00AM  Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin at TheStreet
Mar-12-15 08:20AM  Top Analyst Upgrades and Downgrades: Amarin, CONSOL, Garmin, GNC, HP, Peabody, Windstream and More at 24/7 Wall St. +22.68%
07:10AM  Amarin upgraded by H.C. Wainwright
Mar-11-15 06:01PM  Wednesday's After-Hours Movers: Shake Shack, Box And Others Fall Following Earnings
08:02AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
Mar-06-15 05:10AM  Amarin Announces $52.8 Million Private Placement at noodls +6.59%
05:00AM  Amarin Announces $52.8 Million Private Placement Marketwired
Mar-04-15 08:12AM  New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit at noodls +9.74%
08:00AM  New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit Marketwired
Mar-03-15 04:27PM  Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 at noodls
04:27PM  Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015 at noodls
04:27PM  Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations at noodls
04:00PM  Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations Marketwired
Mar-02-15 04:05PM  Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015 Accesswire
01:00PM  What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog Zacks
Feb-28-15 08:01PM  Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog Zacks
Feb-27-15 04:22PM  Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog Zacks
04:18PM  Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog Zacks
01:30PM  Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog Zacks
11:10AM  Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog Zacks
Feb-26-15 10:50AM  What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Zacks +5.04%
09:16AM  Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl) in China Marketwired
Feb-25-15 11:00AM  Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog Zacks
08:45AM  Should You Buy Amarin Corporation (AMRN) Ahead of Earnings? - Tale of the Tape Zacks
Feb-24-15 04:10PM  Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog Zacks
03:40PM  Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog Zacks
01:50PM  Will Ingram Micro (IM) Miss Earnings Estimates in Q4? - Analyst Blog Zacks
12:40PM  What's in Store for OmniVision (OVTI) This Earnings? - Analyst Blog Zacks
Feb-23-15 04:30PM  Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 Marketwired +6.77%
09:13AM  Can The Uptrend Continue for Amarin (AMRN)? - Tale of the Tape Zacks
Feb-10-15 02:01PM  4 Biotech Stocks Under $10 Triggering Breakouts: Amarin, Exelixis and More at TheStreet
Jan-12-15 08:01AM  AMARIN CORP PLC\UK Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Jan-05-15 07:00AM  Amarin to Present at the 33rd Annual J.P. Morgan Healthcare Conference Marketwired -6.19%
Dec-04-14 07:00AM  Amarin to Present at the 25th Annual Oppenheimer Healthcare Conference Marketwired
Nov-19-14 06:12AM  Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% Zacks -5.30%
Nov-17-14 09:00AM  Amarin Announces Presentation of MARINE and ANCHOR Analyses at the American Heart Association Scientific Sessions Showing Vascepa(R) Significantly Reduced Remnant-Like Particle Cholesterol in Hypertriglyceridemic Patients Marketwired +12.66%
Nov-14-14 04:43PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
Nov-13-14 07:00AM  Rick Harrison of Television's "Pawn Stars(R)" Takes His Patient-Care Message to AHA Scientific Sessions to Raise Awareness of Very High Triglycerides as Part of National Campaign Marketwired +6.98%
Nov-06-14 04:02PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.